Ramipril Capsule Medication Recalled Over Unapproved Vendor Manufacturing Deviations
Lupin Pharmaceuticals is recalling 357,414 bottles of Ramipril 10 mg capsules due to CGMP deviations where the active pharmaceutical ingredient was sourced from an unapproved vendor. The affected product was distributed to 30 wholesalers with potential nationwide distribution.
- Product
- RAMIPRIL — RAMIPRIL (RAMIPRIL)
- Category
- Drug
- Distribution
- Distributed nationwide